These genes contain the blueprint for the ion channels TRPA1 and
NaV1.7. It is already known that these two channels are involved in the perception of pain.
Similar questions are at hand for the
Nav1.7 inhibitor that Biogen had taken over from Convergence Pharmaceuticals.
Nav1.7 sodium channel-induced Ca2+ influx decreases tau phosphorylation via glycogen synthase kinase-3beta in adrenal chromaffin cells.
Two types of VGSCs,
Nav1.7 and Nav1.8, are known to contribute to pain transduction in nociceptive neurons [21, 22].
A new study has just revealed that the antinociceptive effects of BTX-A are conferred by inhibiting
Nav1.7 upregulation in the trigeminal ganglion [24].
Since nerve damage from diabetic hyperglycemia causes pain, several existing and potential pain drugs and Chromocell novel
NaV1.7 blocker compound were evaluated as pain treatments in the subject animals.
Zhong, "The role of TNF-a/NF-xB pathway on the up-regulation of voltage-gated sodium channel
Nav1.7 in DRG neurons of rats with diabetic neuropathy," Neurochemistry International, vol.
The aim of the partnership is to accelerate Purdue's
Nav1.7 sodium ion channel drug candidates using AnaBios' Phase-X discovery platform to develop treatments for chronic pain.